These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19598281)

  • 1. The effects of racemic albuterol versus levalbuterol in very low birth weight infants.
    Mhanna MJ; Patel JS; Patel S; Cohn R
    Pediatr Pulmonol; 2009 Aug; 44(8):778-83. PubMed ID: 19598281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial.
    Andrews T; McGintee E; Mittal MK; Tyler L; Chew A; Zhang X; Pawlowski N; Zorc JJ
    J Pediatr; 2009 Aug; 155(2):205-10.e1. PubMed ID: 19464028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial.
    Ralston ME; Euwema MS; Knecht KR; Ziolkowski TJ; Coakley TA; Cline SM
    J Emerg Med; 2005 Jul; 29(1):29-35. PubMed ID: 15961004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.
    Skoner DP; Greos LS; Kim KT; Roach JM; Parsey M; Baumgartner RA
    Pediatr Pulmonol; 2005 Dec; 40(6):477-86. PubMed ID: 16193496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
    Yaseen H; Khalaf M; Dana A; Yaseen N; Darwich M
    Am J Perinatol; 2008 Mar; 25(3):193-7. PubMed ID: 18425722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.
    Donohue JF; Parsey MV; Andrews C; D'Urzo T; Sharma S; Schaefer K; Claus R; Baumgartner RA;
    COPD; 2006 Aug; 3(3):125-32. PubMed ID: 17240614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine in very low birth weight infants during their first days of life.
    Auron A; Mhanna MJ
    J Perinatol; 2006 Dec; 26(12):755-60. PubMed ID: 17036033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients.
    Kelly A; Kennedy A; John BM; Duane B; Lemanowicz J; Little J
    Ann Pharmacother; 2013 May; 47(5):644-50. PubMed ID: 23613097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
    Truitt T; Witko J; Halpern M
    Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial.
    Karadag B; Ceran O; Guven G; Dursun E; Ipek IO; Karakoc F; Ersu RH; Bozaykut A; Inan S; Dagli E
    Respiration; 2008; 76(3):283-7. PubMed ID: 18042975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.
    Nowak RM; Emerman CL; Schaefer K; Disantostefano RL; Vaickus L; Roach JM
    Am J Emerg Med; 2004 Jan; 22(1):29-36. PubMed ID: 14724875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates.
    Fayon M; Tayara N; Germain C; Choukroun ML; De La Roque ED; Chêne G; Breilh D; Marthan R; Demarquez JL
    Neonatology; 2007; 91(3):167-73. PubMed ID: 17377401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to inhaled bronchodilators in infancy are not linked with asthma in later childhood.
    Hyvärinen MK; Kotaniemi-Syrjänen A; Reijonen TM; Korhonen K; Kiviniemi V; Korppi M
    Pediatr Pulmonol; 2006 May; 41(5):420-7. PubMed ID: 16547959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation.
    Levin DL; Garg A; Hall LJ; Slogic S; Jarvis JD; Leiter JC
    Pediatr Crit Care Med; 2008 Nov; 9(6):598-604. PubMed ID: 18838938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levalbuterol and racemic albuterol: are there therapeutic differences?
    Ahrens R; Weinberger M
    J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost effectiveness of levalbuterol versus racemic albuterol.
    Quinn C
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S153-7. PubMed ID: 15354680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.